Bulletin

This bulletin and supporting resources provide practical guidance on deprescribing. Support tools include a medication review template and deprescribing algorithms which are both generic and drug class ...
These guidelines update the previous ONS guidelines and set out the steps for prescribing ONS and provide useful advice on monitoring progress as well as for prescribing in malnutrition associated with ...
This bulletin discusses the implementation of NICE guidance relevant to medicines optimisation in care homes. A summary of relevant NICE guidance and suggestions to support implementation are offered for ...
Created on 07 April 2017
This bulletin reviews the place in therapy of barrier preparations and includes resources which focus on using products appropriately and avoiding waste.  A pathway and formulary product selection ...
The controlled drugs bulletin and resources have been written to support CCG teams that have a role in supporting the regional NHS England Controlled Drugs Accountable Officer (CDAO).  An audit ...
This bulletin and briefing review the place in therapy for silicone sheets and gels for the treatment of scar reduction. The supporting datapack shows local usage of these products.     Wound ...
This bulletin reviews the use of rectal irrigation to ensure proper pathways are in place before prescribing and wastage is reduced through appropriate prescribing. It is a supporting bulletin for the ...
These resources review the place in therapy for silk and antimicrobial garments to ensure to ensure prescribing is appropriate and excessive quantities of garments are not prescribed. The evidence to support ...
Created on 02 February 2017
Due to concerns over hypnotic dependence, hypnotic prescribing has been subject to scrutiny and review for a number of years. In this bulletin, we offer advice on managing new patients with insomnia, recommend ...
...  DROP list devices bulletin compliments the DROP list bulletin and looks at the place in therapy for certain medical devices. Recommendations range from reviewing use and pathways to reduce potential wastag ...
This bulletin and associated resources support medicines optimisation in non neuropathic (non cancer) pain.  It looks at the place in therapy of different pain treatments and also helps identify where ...
This bulletin, briefing and supporting resources support prescribers in being able to agree the goals of a treatment and discuss the discontinuation criteria with patients before they initiate a treatment. ...
The medicines adherence and waste bulletin with long awaited medicines waste campaign resources are now available on the webiste, The resources include project planning tools, a full video animation, short ...
This bulletin is the latest SPOT(Specials Prescribing Optimisation Tool) support bulletin and focuses on the use of glycopyrronium in hypersalivation (both off label and unlicenced special usage). It also ...
The infant feeds bulletin update is now available for subscribers. The bulletin discusses management and review for several conditions where baby milks may be prescribed and also the review of prescribed ...
Created on 14 November 2016
These resources support the appropriate prescribing and review of ADHD treatments including initiation and monitoring of treatment. An audit is available to support identification of patients needing a ...
This bulletin supports the implementation self administration of medicines in the care home setting for of residents who are able to. Assessment and implementation tools are provided to support change ...
These resources support the effective working and communication between members of a multidisciplinary teams for care home residents. Template paperworks is available which can be adapted locally and be ...
Created on 28 September 2016
... there has been a significant growth in prescribing and those that may not appear very often but when they do pose significant cost pressure due to their expense. The SPOT resource (and supporting bulletins) ...
This bulletin reviews the place in therapy of unlicensed buccal midazolam and switching to a licences product where appropriate. Safety issues and savings are also discussed.   Buccal midazolam ...